OLIVIER BRANDICOURT - 18 May 2023 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
Director
Signature
By: /s/ Stephen Hall, Attorney-in-Fact For: Olivier Brandicourt
Issuer symbol
ALNY
Transactions as of
18 May 2023
Transactions value $
$0
Form type
4
Filing time
19 May 2023, 16:06:18 UTC
Previous filing
20 May 2022
Next filing
23 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Stock Option (right to buy) Award $0 +3.45K $0.00 3.45K 18 May 2023 Common Stock 3.45K $189.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney